Can phosphodiesterase‑5 inhibitor erectile dysfunction medications such as sildenafil (Viagra), tadalafil (Cialis), or vardenafil (Levitra) cause varicose veins?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ED Medications Do Not Cause Varicose Veins

Phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil, and avanafil) do not cause varicose veins. This concern is not supported by any clinical evidence, and varicose veins are not listed among the known adverse effects of these medications in either major clinical guidelines or FDA drug labeling.

Known Side Effects of PDE5 Inhibitors

The established adverse events associated with PDE5 inhibitors are well-documented and do not include varicose veins or any venous pathology 1, 2:

Common side effects include:

  • Headache
  • Indigestion/dyspepsia
  • Back pain
  • Muscle aches (myalgia)
  • Flushing
  • Nasal congestion
  • Visual disturbances

These side effects are typically mild and resolve within a few hours to 2 days 1, 2.

Uncommon but serious side effects:

  • Priapism (erection lasting >4 hours)
  • Sudden vision loss (rare)
  • Sudden hearing loss (rare)

Mechanism of Action and Vascular Effects

PDE5 inhibitors work by enhancing blood flow through smooth muscle relaxation in the corpus cavernosum, not by affecting venous valve function or venous wall integrity 2, 3. These medications are mild arterial vasodilators that cause small decreases in blood pressure through their effects on arterial smooth muscle 3, 4.

The pharmacological action is fundamentally different from mechanisms that would cause varicose veins, which result from:

  • Venous valve incompetence
  • Chronic venous insufficiency
  • Increased venous pressure
  • Structural weakness of venous walls

Clinical Evidence

Extensive clinical trials involving approximately 250,000 men in the general ED population and 25,000 men with specific comorbidities have been conducted with PDE5 inhibitors 1. None of these studies have identified varicose veins as an adverse event or complication.

The most recent comprehensive guidelines from the European Association of Urology (2025) and the American Urological Association (2018) make no mention of varicose veins as a concern with PDE5 inhibitor use 5, 1.

Clinical Reassurance

Patients can be confidently reassured that ED medications do not cause varicose veins. If a patient develops varicose veins while taking these medications, the varicose veins are unrelated to the PDE5 inhibitor and should be evaluated for standard risk factors such as:

  • Age
  • Prolonged standing
  • Obesity
  • Family history
  • Pregnancy history (in women)
  • Prior deep vein thrombosis

The temporal association would be coincidental rather than causal.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.